Key facts
- This page summarizes David Silberman's Form 3 filing for ORAMED PHARMACEUTICALS INC. (ORMP).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 08 Jul 2021, 16:30.
David Silberman - 05 Jul 2021 Form 3 Insider Report for ORAMED PHARMACEUTICALS INC. (ORMP)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- ORMP
- Reported as of
- 05 Jul 2021
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 08 Jul 2021, 16:30:13 UTC
- Next SEC filing
- 02 Sep 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ David Silberman
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
David Silberman filed Form 3 for ORAMED PHARMACEUTICALS INC. (ORMP) on 08 Jul 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Additional SEC filing notes
Filing notes and footnotes
Ownership status
The filing reports no beneficially owned securities.